CURE’s thyroid cancer page is an extensive resource of cancer information featuring the latest thyroid cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on thyroid cancer.
July 21st 2021, 4:05pm
Resources available to support patients and community oncologists who are interested in learning more and gaining access to comprehensive biomarker testing.
June 23rd 2021, 2:06pm
Lori J. Wirth, MD, describes what information she looks for from results of molecular testing that help inform treatment for her patients with thyroid cancer.
June 23rd 2021, 1:58pm
Andrea Ferris, of the LUNGevity Foundation, explains why shared decision-making is important when recommending molecular testing to patients with lung or thyroid cancer and highlights resources provided through her organization that support patients and health care professionals.
June 16th 2021, 3:21pm
Common questions asked by patients with lung or thyroid cancer who have been referred for biomarker testing and advice for setting expectations from test results.
June 16th 2021, 3:15pm
Drs Benjamin Levy and Lori J. Wirth comment on the current role of liquid biopsies in lung and thyroid cancer.
June 9th 2021, 2:45pm
Recommendations for selecting appropriate patients for comprehensive genomic profiling and navigating through the testing process.
June 9th 2021, 2:35pm
Drs Benjamin Levy and Lori J. Wirth describe how they currently utilize comprehensive genomic profiling to manage patients with non–small cell lung cancer or thyroid cancer.
May 20th 2021, 2:40pm
New research sheds lights on the causes of thyroid cancer, overdiagnosis of PTC
March 16th 2021, 9:00pm
Data from a recent study found that while the risk of developing cancer is 1.74 times greater for individuals born with major birth defects, that risk is highest in childhood but decreases slightly after age 20.
December 1st 2020, 8:36pm
The drug has been approved to treat patients with advanced or metastatic RET-mutant medullary thyroid cancer and RET fusion-positive thyroid cancer.
Beyond the Diagnosis: A Stage-by-Stage Guide to Multiple Myeloma Treatment
FDA Approves Bosaya and Aukelso Biosimilars for Solid Tumor Care
How to Access Support Resources for Rare Cancers
The Defining Moments of Support After Hearing ‘You Have Cancer’